Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Syndax Announces U.S. FDA Breakthrough Therapy Designation Granted for Patients with Relapsed or Refractory KMT2A- Rearranged (MLLr) Acute Leukemia
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced […]
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
Lynk Pharmaceuticals, an innovative clinical-stage company, announced that it has dosed the first patient in […]
Liminatus Pharma and Iris Acquisition Corp to Combine to Incorporate and Accelerate Much-needed Cancer Treatments
Liminatus Pharma LLC, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition […]
Alzheimer's Association Statement on Lecanemab Phase 3 Full Results
The Alzheimer’s Association welcomes, and is further encouraged by the full Phase 3 data presented […]
New Funding of $2 Million for Research Bringing Us One Step Closer to a Cure for Follicular Lymphoma
The Follicular Lymphoma Foundation (FLF) today announced it has awarded four research grants of up to […]
Hansa Biopharma Announces Positive Topline Data from a Study in Antibody Mediated Rejection (AMR) Post Kidney Transplantation
Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, today announces positive […]
Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Exscientia has announced clinical trial application (CTA) approval of IGNITE-AI, enabling site activation in its […]
Chemotherapy May be Completed within 8 days with Two Doses of Polytaxel, an Innovative Anticancer Drug from South Korea's Biotech Firm
An innovative anticancer therapy that may complete chemotherapy with two doses of an anticancer drug […]
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development
XtalPi have announced that they are embarking on a strategic collaboration with CK Life Sciences, […]
World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks
A potential new drug to improve the long-term outcomes for patients who suffer heart attacks […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more